These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25630954)

  • 21. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.
    Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group.
    Miser JS; Goldsby RE; Chen Z; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore SG; Rausen AR; Vietti TJ; Grier HE
    Pediatr Blood Cancer; 2007 Dec; 49(7):894-900. PubMed ID: 17584910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.
    Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy Comparison of Six Chemotherapeutic Combinations for Osteosarcoma and Ewing's Sarcoma Treatment: A Network Meta-Analysis.
    Zhang T; Zhang S; Yang F; Wang L; Zhu S; Qiu B; Li S; Deng Z
    J Cell Biochem; 2018 Jan; 119(1):250-259. PubMed ID: 28266080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved Outcome in Local Ewing Sarcoma With an Intensified Pilot Treatment Protocol SCMCIE 94.
    Ash S; Yaniv I; Toledano H; Stein J; Kollender Y; Fenig E; Konen O; Bar-Sever Z; Issakov J; Avigad S; Cohen IJ
    J Pediatr Hematol Oncol; 2019 Mar; 41(2):105-111. PubMed ID: 30570510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma.
    Worden FP; Taylor JM; Biermann JS; Sondak VK; Leu KM; Chugh R; McGinn CJ; Zalupski MM; Baker LH
    J Clin Oncol; 2005 Jan; 23(1):105-12. PubMed ID: 15625365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local control in Ewing sarcoma of the chest wall: results of the EURO-EWING 99 trial.
    Bedetti B; Wiebe K; Ranft A; Aebert H; Schmidt J; Jürgens H; Dirksen U
    Ann Surg Oncol; 2015 Sep; 22(9):2853-9. PubMed ID: 26104542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis.
    Patel SR; Papadopolous N; Raymond AK; Donato M; Seong CM; Yasko AW; Lewis VO; Lin PP; Champlin R; Benjamin RS
    Cancer; 2004 Jul; 101(1):156-63. PubMed ID: 15222001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: the Dana-Farber Cancer Institute/Children's Hospital experience.
    McLean TW; Hertel C; Young ML; Marcus K; Schizer MA; Gebhardt M; Weinstein HJ; Perez-Atayde A; Grier HE
    J Pediatr Hematol Oncol; 1999; 21(6):486-93. PubMed ID: 10598659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors.
    Tanaka K; Matsunobu T; Sakamoto A; Matsuda S; Iwamoto Y
    J Orthop Sci; 2002; 7(4):477-82. PubMed ID: 12181663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pelvis Ewing sarcoma: Local control and survival in the modern era.
    Ahmed SK; Robinson SI; Arndt CAS; Petersen IA; Haddock MG; Rose PS; Issa Laack NN
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28244685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term Outcomes and Complications in Pediatric Ewing Sarcoma.
    Hamilton SN; Carlson R; Hasan H; Rassekh SR; Goddard K
    Am J Clin Oncol; 2017 Aug; 40(4):423-428. PubMed ID: 25599318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ewing sarcoma/primitive neuroectodermal tumor of the kidney treated with chemotherapy including ifosfamide.
    Yoshihara H; Kamiya T; Hosoya Y; Hasegawa D; Ogawa C; Asanuma H; Mizuno R; Hosoya R; Manabe A
    Pediatr Int; 2016 Aug; 58(8):766-9. PubMed ID: 27324740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adolescent-adult nonmetastatic Ewing sarcoma-Experience from a large developing country.
    Bajpai J; Panda GS; Chandrasekharan A; Bhargava P; Srinivas S; Laskar S; Dandekar S; Mokal S; Rekhi B; Khanna N; Menon N; Patil V; Noronha V; Joshi A; Prabhash K; Banavali SD; Gupta S
    Pediatr Blood Cancer; 2021 Sep; 68(9):e29081. PubMed ID: 33991401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol.
    Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Mohanti BK; Sharma MC; Vishnubhatla S; Bakhshi S
    J Surg Oncol; 2015 May; 111(6):683-9. PubMed ID: 25557999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen.
    Vijayasekharan K; Ramanathan S; Chinnaswamy G; Prasad M; Gulia A; Janu A; Rekhi B; Ramadwar M; Khanna N; Laskar S; Puranadare N; Bajpai J; Puri A; Banavali S; Vora T
    J Adolesc Young Adult Oncol; 2021 Apr; 10(2):185-192. PubMed ID: 32706630
    [No Abstract]   [Full Text] [Related]  

  • 37. Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma.
    Cormier JN; Patel SR; Herzog CE; Ballo MT; Burgess MA; Feig BW; Hunt KK; Raney RB; Zagars GK; Benjamin RS; Pisters PW
    Cancer; 2001 Sep; 92(6):1550-5. PubMed ID: 11745234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cutaneous and subcutaneous Ewing sarcoma.
    Di Giannatale A; Frezza AM; Le Deley MC; Marec-Bérard P; Benson C; Blay JY; Bui B; Judson I; Oberlin O; Whelan J; Gaspar N
    Pediatr Blood Cancer; 2015 Sep; 62(9):1555-61. PubMed ID: 25894676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Painful peripheral neuropathy after treatment with high-dose ifosfamide.
    Frisk P; Stålberg E; Strömberg B; Jakobson A
    Med Pediatr Oncol; 2001 Oct; 37(4):379-82. PubMed ID: 11568902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
    Shkalim-Zemer V; Ash S; Toledano H; Kollender Y; Issakov J; Yaniv I; Cohen IJ
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):909-16. PubMed ID: 26365289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.